AFYREN SAS

ENXTPA:ALAFY Stock Report

Market Cap: €60.5m

AFYREN SAS Valuation

Is ALAFY undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ALAFY when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate ALAFY's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate ALAFY's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ALAFY?

Key metric: As ALAFY is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for ALAFY. This is calculated by dividing ALAFY's market cap by their current revenue.
What is ALAFY's PS Ratio?
PS Ratio21.7x
Sales€2.79m
Market Cap€60.52m

Price to Sales Ratio vs Peers

How does ALAFY's PS Ratio compare to its peers?

The above table shows the PS ratio for ALAFY vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average12.4x
PVL Plastiques du Val de Loire
0.03x-1.9%€26.9m
EXPL EPC Groupe
0.8x4.2%€396.5m
ALGBE Global Bioenergies
29x27.6%€14.1m
MLPRX Parx Materials
19.7xn/a€3.3m
ALAFY AFYREN SAS
21.7x98.8%€60.5m

Price-To-Sales vs Peers: ALAFY is expensive based on its Price-To-Sales Ratio (21.7x) compared to the peer average (12.4x).

Price to Sales Ratio vs Industry

How does ALAFY's PS Ratio compare vs other companies in the FR Chemicals Industry?

4 CompaniesPrice / SalesEstimated GrowthMarket Cap
SEFER SergeFerrari Group
0.2x3.7%US$74.25m
ORAP Orapi
0.2x1.6%US$44.26m
PVL Plastiques du Val de Loire
0.03x-1.9%US$28.29m
METEX METabolic EXplorer
0.04xn/aUS$6.75m
No more companies available in this PS range
ALAFY 21.7xIndustry Avg. 1.0xNo. of Companies4PS01.22.43.64.86+
4 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: ALAFY is expensive based on its Price-To-Sales Ratio (21.7x) compared to the European Chemicals industry average (1x).

Price to Sales Ratio vs Fair Ratio

What is ALAFY's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ALAFY PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio21.7x
Fair PS Ratio2.4x

Price-To-Sales vs Fair Ratio: ALAFY is expensive based on its Price-To-Sales Ratio (21.7x) compared to the estimated Fair Price-To-Sales Ratio (2.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ALAFY forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€2.32
€4.53
+95.4%
14.6%€5.00€3.60n/a3
Nov ’25€2.37
€4.53
+91.3%
14.6%€5.00€3.60n/a3
Oct ’25€2.81
€5.03
+79.1%
23.5%€6.50€3.60n/a3
Sep ’25€2.99
€5.03
+68.3%
23.5%€6.50€3.60n/a3
Aug ’25€2.89
€5.03
+74.2%
23.5%€6.50€3.60n/a3
Jul ’25€1.94
€5.75
+196.4%
13.0%€6.50€5.00n/a2
Jun ’25€2.60
€5.75
+121.2%
13.0%€6.50€5.00n/a2
May ’25€2.72
€5.75
+111.4%
13.0%€6.50€5.00n/a2
Apr ’25€1.90
€6.30
+231.6%
20.6%€7.60€5.00n/a2
Mar ’25€1.57
€7.17
+356.5%
22.6%€8.90€5.00n/a3
Feb ’25€2.01
€7.17
+256.6%
22.6%€8.90€5.00n/a3
Jan ’25€1.99
€7.17
+261.0%
22.6%€8.90€5.00n/a3
Dec ’24€2.41
€8.60
+256.8%
4.9%€8.90€8.00n/a3
Nov ’24€3.09
€8.60
+178.3%
4.9%€8.90€8.00€2.373
Oct ’24€4.61
€8.60
+86.6%
4.9%€8.90€8.00€2.813
Sep ’24€5.24
€8.77
+67.3%
6.6%€9.40€8.00€2.993
Aug ’24€5.60
€8.77
+56.5%
6.6%€9.40€8.00€2.893
Jul ’24€5.68
€8.77
+54.3%
6.6%€9.40€8.00€1.943
Jun ’24€4.81
€8.77
+82.3%
6.6%€9.40€8.00€2.603
May ’24€4.54
€8.77
+93.1%
6.6%€9.40€8.00€2.723
Apr ’24€4.40
€8.77
+99.2%
6.6%€9.40€8.00€1.903
Mar ’24€5.98
€9.30
+55.5%
9.3%€10.50€8.50€1.573
Feb ’24€6.39
€9.30
+45.5%
9.3%€10.50€8.50€2.013
Jan ’24€5.80
€9.30
+60.3%
9.3%€10.50€8.50€1.993
Dec ’23€5.82
€9.30
+59.8%
9.3%€10.50€8.50€2.413
Nov ’23€5.08
€9.30
+83.1%
9.3%€10.50€8.50€3.093

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

TFF Group

€687.3m

Manufactures and distributes barrels and wood products for the aging of wines and alcohols in France, rest of Europe, the United States, Asia, and internationally.

TFF

€31.50

7D

-1.9%

1Y

-24.8%

Groupe Berkem Société anonyme

€54.0m

Operates in the chemical industry.

ALKEM

€3.07

7D

0.3%

1Y

115.4%

Plastiques du Val de Loire

€26.9m

Manufactures and sells plastic parts in Europe and North America.

PVL

€1.20

7D

1.7%

1Y

-55.7%